Zobrazeno 1 - 10
of 887
pro vyhledávání: '"35"'
Autor:
Marion David, Marie Degremont, Agnès Loeb, Zena Khaznadar, Marianne Leheurteur, Anne Perdrix, Frédéric Di Fiore, Mathilde Saint-Ghislain, Florian Clatot
Publikováno v:
Reproductive BioMedicine
Reproductive BioMedicine Online, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
Reproductive BioMedicine Online, Elsevier, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
Reproductive BioMedicine Online, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
Reproductive BioMedicine Online, Elsevier, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
The impact of chemotherapy on fertility appears to be of essential importance for the youngest cancer survivors. The aim of this study was to assess plasma anti-Mullerian hormone (AMH) evolution, using an automated sensitive AMH immunoassay in women
Publikováno v:
Transfusion and Apheresis Science. 57:672-675
Background Extended phenotyping is one of the important method of reducing red cell alloimmunisation. Extended phenotyping of red cells from voluntary donors have many uses in addition to its application in population genetics. As there was very litt
Autor:
Maria Rios, François Le Loarer, Virginie Audard, François Sirveaux, Emilie Lardenois, Anne Gomez-Brouchet, Corinne Bouvier, Mathilde Treffel, Guillaume Gauchotte, Jean-Michel Vignaud, Marie Karanian, Sébastien Aubert, Béatrice Marie, Gonzague de Pinieux, Frédérique Larousserie
Publikováno v:
The American journal of surgical pathology. 44(1)
Denosumab, an antibody directed against receptor activator of nuclear factor-κB ligand (RANKL), has recently been introduced in the treatment strategy of giant cell tumor of bone. In this study, we assessed the tumor changes induced by denosumab in
Autor:
J. L. Gottschall, Nina Mufti, Salvador Rico, Anna Erickson, Neeta Rugg, N. Huang, Laurence Corash, Jose A. Cancelas, Anne North, Sharon Graminske, M. A. Schott
Publikováno v:
Vox Sanguinis. 112:210-218
Background and Objectives Pathogen reduction technology using amustaline (S-303) was developed to reduce the risk of transfusion-transmitted infection and adverse effects of residual leucocytes. In this study, the viability of red blood cells (RBCs)
Publikováno v:
Histopathology. 71(5)
Aims Uterine leiomyosarcomas frequently show p16 immunoexpression. However, p16 may also be expressed in some benign leiomyoma variants such as leiomyomas with bizarre nuclei and cellular leiomyomas, limiting its utility as a biomarker to distinguish
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 17(3)
Central neurocytomas are rare neuronal neoplasms with a favorable prognosis. They are typically located in the lateral ventricles of the brain and mostly histologically correspond to WHO grade II with a Mib 1 labelling index of2%. Similar tumors loca
Autor:
John I. Risinger, Shyamal D. Peddada, Pierre R. Bushel, Donna D. Baird, Barbara J. Davis, Gadisetti V.R. Chandramouli
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e63909 (2013)
PLoS ONE
PLoS ONE
The study of uterine leiomyomata (fibroids) provides a unique opportunity to investigate the physiological and molecular determinants of hormone dependent tumor growth and spontaneous tumor regression. We conducted a longitudinal clinical study of pr
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Interleukin (IL)-35-secreting B (IL-35+B) cells are critical regulators in autoimmune and infectious diseases and exert suppressive functions in parallel with IL-10-producing B (B10) cells. However, the role of IL-35+B cells in persistent hepatitis B
Autor:
Lanlan Yang, Siqi Liu, Zhenjing Jin, Xue Shao, Qian Zhang, Jie Song, Shengnan Jia, Wudong Wang
Publikováno v:
Virology Journal
Virology Journal, Vol 16, Iss 1, Pp 1-10 (2019)
Virology Journal, Vol 16, Iss 1, Pp 1-10 (2019)
Background Interleukin (IL)-35 regulates imbalance between regulatory T cells (Tregs) and T helper (Th) 17 cells, leading to an important modulator in autoimmune disorder, cancer, and infectious diseases. Our previous study revealed an immunosuppress
Autor:
Yuqing Dong, Yixiang Han, Yisha Huang, Songfu Jiang, Ziyang Huang, Rongrong Chen, Zhijie Yu, Kang Yu, Shenghui Zhang
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Intratumoral accumulation of CD4+CD25+Foxp3+ regulatory T (Treg) cells occurs in acute myeloid leukemia (AML), but little is known about the role of tumor cells themselves in this process. Here, we showed that an immune checkpoint PD-L1 expressed by